FindTrial
Sign In

A Randomized Controlled Study About the Safety and Efficacy of Intraoperative Intraperitoneal Hyperthermia for Pancreatic Cancer Patients

A Randomized Controlled Study About the Safety and Efficacy of Intraoperative Intraperitoneal Hyperthermia for Pancreatic Cancer Patients

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800014254
Enrollment
Unknown
Registered
2018-01-02
Start date
2019-08-01
Completion date
Unknown
Last updated
2018-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic Cancer

Interventions

Study group:Surgery and intraoperative hyperthermia
Control group:Surgery

Sponsors

2end Hospital Attached to Hebei Medical University,Shijiazhuang,Hebei,China
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged = 80 years; 2. Diagnosed with pancreatic cancer by lab examination and CT scan preoperaitvely; 3. Life expectancy > 3 Months; 4. Acceptable heart,lung,liver and kidney founction; 5. No preoperative chemotherapy or radiotherapy; 6. Signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Intraoperative death; 2. R0 resection is not available; 3. water perfusion volume < 1000ml; 4. abdominal inflammatory disease; 5. Postoperative pathology demonstrated no pancreatic cancer or Positive margin.

Design outcomes

Primary

MeasureTime frame
Survival time;Tumor markers;Morbidity;Other surgery related data;Recurrence;—

Countries

China

Contacts

Public ContactLIU Jianhua

2end Hospital Attached to Hebei Medical University,Shijiazhuang,Hebei,China

ljh@medmail.com.cn+86 15803210528

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026